CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol Primary Prevention of Heart Failure in Women Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction Determinants of exercise intolerance in heart failure with preserved ejection fraction: A systematic review and meta-analysis The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

JOURNAL: Article Link

南京市第一医院心血管内科为多名复杂性肺高压患者实施肺血管介入治疗

qiaomingyue Keywords: 近年来,肺动脉高压在病理机制、诊断、风险评估及治疗等方面有诸多新进展,治疗策略不断更新,交感神经学说在肺动脉高压发生及发展中起着重要作用。经皮肺动脉去神经术(percutaneous pulmonary artery denervation,PADN)由陈绍良教授创新发明并成功开展后,越来越多的研究证据均显示其良好的疗效及广阔的前景,随着这一技术在全球的普及,肺动脉高压的治疗已经迈入在靶向药物治疗基础上的介入治疗新时代。

网站资料更新中...